Sylphar is a Belgium-based developer, manufacturer and marketer of OTC products for the healthcare industry across the globe.
Business Model:
Revenue: $74.5M
Employees: 51-200
Sylphar was acquired by
Karo Pharma AB.
The acquisition happend on 2021-11-23.
Details of the transaction were not public
Address: Xavier De Cocklaan 24
City: Deurle
State: flemish brabant
Zip: 9831
Country: BE
Sylphar is a Belgium-based developer, manufacturer and marketer of OTC products for the healthcare industry across the globe.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2017 | Private Equity Round | - |
Vendis Capital Vendis Capital |
5/2017 | Equity | - | 5/2017 | Equity | - |
Vendis Capital Vendis Capital |
5/2017 | Private Equity Round | 1 | - |
Vendis Capital Vendis Capital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|